Skip to main content

Leukocyte Count Predictor of Future Long COVID Severity in Postmenopausal Women

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 29, 2025.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Jan. 29, 2025 -- Leukocyte count is an independent predictor of future postacute sequelae of severe acute respiratory coronavirus 2 infection (PASC) in postmenopausal women, according to a study published online Jan. 28 in Menopause.

Ted K.S. Ng, Ph.D., from Rush University Medical Center in Chicago, and colleagues examined the association of leukocyte count and high-sensitivity C-reactive protein (hsCRP) concentrations measured about 25 years prior to the COVID-19 pandemic with PASC, PASC severity (defined as the sum of PASC symptoms), and PASC-associated cognitive outcomes among postmenopausal women. Multivariable regression models were constructed using biomarker data from blood specimens collected during prepandemic enrollment (1993 to 1998) and data on 1,237 Women's Health Initiative participants who completed a COVID-19 survey between June 2021 and February 2022.

After controlling for baseline characteristics, the researchers identified positive associations between logc-transformed leukocyte count and leukocyte count ≥5.5 x 1,000 cells/µL with PASC severity (β = 0.27 and 0.13, respectively), but not with PASC occurrence or PASC-related cognitive outcomes. Only about 27 percent of participants had data on hsCRP concentration, which was not associated with any of the PASC outcomes.

"Our study extends the evidence that low-grade inflammation is not only a correlate or an outcome of PASC severity, but also precedes the acute COVID-19 infection leading to this debilitating outcome, further supporting a role of inflammation in the etiology of PASC," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted January 2025

Further Support and Information on COVID-19

Read this next

All-Cause Mortality Higher With Sleep Deprivation in Seniors With Epilepsy

MONDAY, May 19, 2025 -- Older adults with sleep deprivation and epilepsy have an elevated risk for all-cause mortality, according to a study published online April 23 in...

Medicaid Unwinding Linked to Disruption of Chronic Medication Therapy in Youth

FRIDAY, May 16, 2025 -- In young patients, especially young adults, Medicaid unwinding associated with the COVID-19 pandemic disrupted chronic medication therapy, according to a...

More Research Needed to Prepare People With Mental Illness for Menopause

THURSDAY, May 15, 2025 -- Few studies examine how people living with a mental illness may be best prepared for the menopause transition, considering both menopause symptoms and...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.